CN1768791A - 一种蠲痺定痛的中药制剂 - Google Patents
一种蠲痺定痛的中药制剂 Download PDFInfo
- Publication number
- CN1768791A CN1768791A CNA200510018097XA CN200510018097A CN1768791A CN 1768791 A CN1768791 A CN 1768791A CN A200510018097X A CNA200510018097X A CN A200510018097XA CN 200510018097 A CN200510018097 A CN 200510018097A CN 1768791 A CN1768791 A CN 1768791A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- parched
- herba
- myrrha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000002193 Pain Diseases 0.000 title claims abstract description 36
- 230000036407 pain Effects 0.000 title claims abstract description 36
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 claims abstract description 20
- 239000003814 drug Substances 0.000 claims description 62
- 210000000582 semen Anatomy 0.000 claims description 29
- 229940079593 drug Drugs 0.000 claims description 28
- 241001057584 Myrrha Species 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 9
- 241000132012 Atractylodes Species 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 241001465251 Ephedra sinica Species 0.000 abstract 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000107975 Strychnos nux-vomica Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 206010033799 Paralysis Diseases 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 210000003414 extremity Anatomy 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 206010039073 rheumatoid arthritis Diseases 0.000 description 6
- 244000052769 pathogen Species 0.000 description 5
- 206010019468 Hemiplegia Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000012907 honey Nutrition 0.000 description 4
- 208000027753 pain disease Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 210000001113 umbilicus Anatomy 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010005963 Bone formation increased Diseases 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 201000001263 Psoriatic Arthritis Diseases 0.000 description 2
- 208000036824 Psoriatic arthropathy Diseases 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 231100000567 intoxicating Toxicity 0.000 description 2
- 230000002673 intoxicating effect Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001617 migratory effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 229940126532 prescription medicine Drugs 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- 208000008822 Ankylosis Diseases 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000045500 Diseae Species 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010023198 Joint ankylosis Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 206010033892 Paraplegia Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000669298 Pseudaulacaspis pentagona Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000026214 Skeletal muscle atrophy Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000025185 skeletal muscle atrophy Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种蠲痺定痛的中药制剂,主要选用马钱子,苍术,麻黄,桂枝等味原料中药,为了提高疗效还增加黄芪,仙灵脾,当归,白术,薏苡仁,白芍等味中药制备而成,以丸剂为好,在祛风湿,通经络,消结肿,止疼痛的基础上采用了调补阴阳气血,健脾养肝益肾,增强自身免疫功能,组方严谨,形成合力,具有养正,通阳,行痺,祛风逐湿和止痛作用,攻补兼施,直达病所以治本,又将近三分之二的浓缩药与主药混和,药少易服,效果倍增,疗效优于他药。经十年临床300余例风湿性关节炎、类风湿性关节炎,骨质增生,偏瘫麻木,腰腿痛等痺痛症患者试用,痊愈率85%,有效率98%,2%无效,从未出现过较大中毒现象。
Description
技术领域
本发明属于中药领域,涉及一种蠲痺定痛的中药制剂。
背景技术
风湿、类风湿、痺痛病是一种以关节病变湿盛为主的全身性免疫性疾病,临床表现反复发作的对称性、多发性小关节炎、以手腕、足关节最易受累,呈现晨僵疼痛肿胀和功能障碍,晚期关节出现不同程度的僵硬和畸形,并骨骼肌肉萎缩,甚至导致残废。
历代医家治疗痺病药方甚多,也都能缓解病情,但治本者不太多,主要是用攻阀药多,而补益增加免疫药少,造成脾胃虚弱,气血化源不足,防御功能低下,脾不胜湿,则水湿流注,经络关节阻滞、气血运行不畅,湿、瘀、毒互结,则关节僵硬,肿胀,痛疼,活动受限,病久失治,用西药抗炎止痛及中医祛风湿治疗进一步损伤脾胃,形成恶性循环,使病情加重。
发明内容
发明人根据中医未病先防,既病防变原则,并认为正气存内邪不相干,邪之所湊,其气必虚,疾病进展必是邪气盛正气虚损所致。类风湿关节炎等痺痛病想治愈,就必须调补阴阳气血健脾养肝益肾,尤以健脾至关重要,风湿、类风湿关节炎是免疫功能紊乱而产生的自身免疫性疾病,只有调节免疫功能才能治愈不复发。
本发明的目的在于研制一种疗效更好的蠲痺定痛的中药制剂,使更多的风湿性关节炎,类风湿性关节炎,骨质增生,偏瘫麻木,腰腿痛等痺痛症患者从疾病的痛苦中解脱出来。
本发明的组方主要采用以下重量份原料药制成:马钱子0.3-120,苍术520-900,麻黄60-120,桂枝400-600,防风430-700,川乌400-800,羌活400-800,没药400-800,杜仲430-800,仙茅310-580。在该组方范围内都有效。
之所以采用上述药物作为主药,是因为马钱子性苦寒,解毒,散结,活络止痛,广泛主治骨折扭伤之瘀血痛疼,经络阻滞,肌无力,截瘫,偏瘫,麻木,顽痺,骨质增生,前列腺增生都能充分发挥通经络强筋骨,祛风湿,消结肿,止疼痛之力,治疗顽痺,尤其显效,故选为君药,由于马钱子有毒,组方用量是发明人经过百余次亲自内服试验得出的适宜用量。由于痺症缠绵难愈,晨僵,肿疼较甚,实为风寒湿三气杂至,以寒湿为主,所以选用苍术,麻黄为臣药,主治湿盛,风寒最强,散邪令足膝有力,防风祛风除湿于毛窍。因为桂枝温通经脉治肩背肢节痛,并治水阻,配合君药以携诸药破下焦主结,一运四旁,使诸肢节瘀阻得通,充分发挥桂枝通达四肢之功。因为防风发表祛风,胜湿止痛,主治风湿项强,骨节酸痛,风行周身,行经络逐湿淫,通关节舒筋骨,活关节起瘫痪;因为川乌祛寒湿,散风邪,通行上下散肌表八风之邪,温经止疼,治风寒湿痺,历节风痛,主半身不遂,驱寒湿有良功;因为羌活散表寒祛风湿,利关节,治风寒湿痺,骨节酸疼,项强筋急,风水浮肿。因为没药散血去瘀,消肿定痛,生肌;因为杜仲补肝、肾、强筋骨,治腰脊酸痛,足膝痿弱,去关节湿淫,充筋力,强阳道,对人体细胞免疫具有双向调节作用。因为仙茅温肾阳、壮筋骨、祛风湿,对细胞免疫低下有升高作用。
先将上述原料药中的马钱子砂炒至膨胀有响爆声并外呈黄色取出放凉,与其它味药共同粉碎,过筛成药粉备用。加蜜(以解马钱子之毒)和匀作丸,每丸6克,油纸包装存放。
为进一步提高治疗效果,本发明还在上述组方药物中增加以下重量份原料药:黄芪500-1000,仙灵脾500-1000,当归300-800,白术500-1000,薏苡仁500-1000,白芍400-600,知母300-400,川芎500-700,丹参700-1000,草乌400-650,龙骨300-600,牡蛎300-600,独活400-600,青风藤400-800,生地黄500-1000,白花蛇舌草500-1000,金银花400-600。在组方2范围内都有效。
之所以增选上述药物,是因为黄芪性辛温,能诱生自身产生干扰素,增强细胞免疫力;仙灵脾又名淫羊藿性辛温,补肾壮阳;当归活瘀血生新血,三药能助组方1中杜仲、仙茅增强自身免疫力;白术性甘温,能补脾益胃燥湿和中,能治克阀药过多而致脾胃虚弱,薏苡仁性甘凉,健脾补肺,清热利湿,二药能助苍术共祛寒湿,以除水邪。白芍苦酸凉,养血柔肝缓中止痛,知母苦寒,滋阴降火,二药配合桂枝宣通阳气化阴邪,以祛肢体浮肿之水,更助组方1祛寒湿除疼痛之功。川芎辛温,行气,开郁祛风燥湿活筋止痛,入太阳经协同防风、羌活增强麻黄、苍术散寒除湿之力。丹参性温,活血化瘀,安神宁心,治骨节疼痛;草乌辛温,能祛寒湿散风邪,温经止疼,治风寒湿痺,历节风,燥湿下行开通关窍,配川乌助马钱子燥寒除湿止疼之力。龙骨、牡蛎性味涩平,镇惊安神不疼入眠,有利疾病好转;独活性辛苦温,能祛风,胜湿散寒止疼,祛风寒湿痺腰膝酸疼手脚挛疼,协羌活专治风湿劳伤上焦下焦之水。青风藤性味苦平,能祛风湿利小便,治风湿痺疼,鹤膝风,水肿脚气,泻下焦血分湿热,肢节肿疼,关节肿大,变形。用生地清热生津。用白花蛇舌草、金银花相配,能治风湿热或初病发热,病中急性发作出现炎症,又有寒症可用二药清热杀菌抗病毒。
为了便与主药混合后药少易服,提高疗效,本发明将上述增选原料药采用水煎浓缩,提取有效成份的方法。即将增选药混和粉碎,加水适量熬煎3小时倒出药液加压取汁,药渣再加适量水继熬3小时取汁,与第一道汁混和再熬,熬至浓缩液为主药粉约2倍重量,倒入组方1药粉搅匀捏之团状,倒出干燥,一并粉碎过100目筛,即成所需药粉加炼蜜和匀作丸,每丸重6克,油纸包装存放。
本发明蠲痺定痛的中药制剂,可以按中药制剂制备成多种剂型,以丸剂为好。每丸重6克,日服二次,早晚饭前各服1丸。孕妇禁忌,严重高血压、肝肾功能不佳者慎服。无论何种剂型,都不影响本发明的保护特征及禁忌事项。
试用临床十年来,治疗300余例风湿性关节炎、类风湿性关节炎、骨质增生、偏瘫麻木、腰腿痛等痺痛症患者,痊愈率85%,有效率98%,2%无效。由于马钱子有毒,所用量是经过发明人多次亲服试验得出的适用范围,所以从未出现过较大中毒现象。由于人的体质年龄有区别,如出现中毒现象,可按传统的缓解方法处理,如用乙醚作轻度麻醉抑制惊厥,或用高锰酸钾洗胃,或用绿豆煮水内服都能很快得到缓解。
由于本发明在前人治疗痺病药方的基础上,采用了调补阴阳气血,健脾养肝益肾,增强自身免疫功能的措施,组方严谨,形成合力,具有养正,通阳行痺,祛风逐湿和营止痛作用,攻补兼施,直达病所以治本;又将近三分之二的浓缩药的有效成份与主药混合,药少易服,药效倍增,疗效优于他药,超过一般。
具体实施方式
本发明蠲痺定痛的中药制剂的实施例1,优选采用以下重量份个原料药制成:炙马钱子0.3,炒苍术520,麻黄60,桂枝400,防风430,制川乌400,羌活400,没药400,炒杜仲430,仙茅310。
将上述个原料中的马钱子砂炒至膨胀,鼓起有响爆声,外呈黄色,切开断面呈紫红红色,取出放凉,与另药共同粉碎,过筛,药粉备用。加炼蜜和匀作丸,每丸6克,油纸包装存用。
本发明的实施例2,优选采用以下重量份个原料药制成:炙马钱子120,炒苍术900,麻黄120,桂枝600,防风700,制川乌800,羌活800,没药800,炒杜仲800,仙茅580。按实施例1的制备方法加工。
本发明的实施例3,优选采用以下重量份个原料药制成:炙马钱子50,炒苍术700,麻黄90,桂枝500,防风600,制川乌600,羌活600,没药600,炒杜仲600,仙茅500。按实施例1的制备方法加工。
本发明的实施例4,为了提高疗效,在实施例1的药物中增加以下重量份个原料药:黄芪500,仙灵脾500,当归300,白术500,生薏苡仁500,白芍400,知母300,川芎500,丹参700,制草乌400,生龙骨300,生牡蛎300,独活400,青风藤400,生地黄500,白花蛇舌草500,金银花400。为便于易服,制备时将上述增加原料药采用浓缩水煎液与实施例1的药粉混和干燥、粉碎、加炼蜜作丸,每丸6克,油纸包装存放。
本发明实施例5,在实施例2的药物中增加以下重量份个原料药:黄芪1000,仙灵脾1000,当归800,白术1000,生薏苡仁1000,白芍600,知母400,川芎700,丹参1000,制草乌650,生龙骨600,生牡蛎600,独活600,青风藤800,生地黄1000,白花蛇舌草1000,金银花600。并按实施例4的制备方法加工。
本发明实施例6,在实施例3的药物中增加以下重量份个原料药:黄芪800,仙灵脾800,当归600,白术800,生薏苡仁800,白芍500,知母350,川芎600,丹参900,制草乌500,生龙骨500,生牡蛎500,独活500,青风藤600,生地黄800,白花蛇舌草800,金银花500。并按实施例4的制备方法加工。
在上述实施例1到实施例6中,所述组方药及其用量是经发明人长期自试及三百余例临床试用后得出的有效组方。
用法:每丸6克,日服二次,早晚饭前各服1丸,一个月为1个疗程。
典型病例1,刘XX,女45岁,驻马店市雪松路人,1998年8月来诊,患者肢体关节节酸痛二年余,尢以双下肢明显屈伸不利步履艰难,遇冷天或劳累诸证加剧,下肢皮肤板硬光滑,捏之不起。曾在市级医院确为类风湿关节炎,口服强的松,阿斯匹林等药疗效不佳,又作检查血沉65mm,类风湿因子阳性。属痺病症气虚血滞,以本发明蠲痺定痛丸一个疗程,早晚饭前半小时各服一次,每次一丸,二诊时酸痛减轻下肢活动有改善,唯有阴雨天仍小痛,效不更方继服蠲痺定痛丸,三个月告愈,一年后随访未复发。
典型病例2,路XX,女36岁,居驻马店市,2004年6月来诊,自述15岁时全身长满银屑癣,经多方治疗不见效,且脾胃损伤。32岁时手腕肘及左右手指肿胀,发粗,经医院确诊银屑病关节炎,痛苦不堪,痒疼不已。查全身上下(包括头部)散长许多钱币大小的底红白屑癣,结痂搔破浸血,关节肿痛晨僵,吃饭有困难,经服本发明丸药,日服二次,早晚饭前各一次,并辅助用药填脐,外贴肢疾宁,20天见轻,先后用药半年,银屑病关节炎均愈。
典型病例3,王XX,男,56岁,住驻马店市风光路中段,患类风湿关节炎多年,反复发作,四肢关节肿胀疼痛游走不定,每逢天气变化,阴雨连绵,疼痛加剧,伴午后五心烦热,头晕气短,乏力,多次服用阿斯匹林,激素药,抗风湿中药,效果不显。1998年初冬来治,到市医院检查抗0960单位,血沉40毫米/小时,脉弦滑舌质紫,苔薄腻,经用本发明丸药早晚饭前各服一次,,每次一丸,连服一个疗程病已见轻,继服两月复查抗O血沉均正常,患者恐复发,要求再服一个疗程,二年后随访未复发。
Claims (8)
1、一种蠲痺定痛的中药制剂,其特征是主要采用以下重量份原料药制成:马钱子0.3-120,苍术520-900,麻黄60-120,桂枝400-600,防风430-700,川乌400-800,羌活400-800,没药400-800,杜仲430-800,仙茅310-580。
2、如权利要求1的一种蠲痺定痛的中药制剂,其特征是可以优选为以下重量份个原料药制成:炙马钱子0.3,炒苍术520,麻黄60,桂枝400,防风430,制川乌400,羌活400,没药400,炒杜仲430,仙茅310。
3、如权利要求1的一种蠲痺定痛的中药制剂,其特征是可以优选为以下重量份个原料药制成:炙马钱子120,炒苍术900,麻黄120,桂枝600,防风700,制川乌800,羌活800,没药800,炒杜仲800,仙茅580。
4、如权利要求1的一种蠲痺定痛的中药制剂,其特征是可以优选为以下重量份个原料药制成:炙马钱子50,炒苍术700,麻黄90,桂枝500,防风600,制川乌600,羌活600,没药600,炒杜仲600,仙茅500。
5、如权利要求1的一种蠲痺定痛的中药制剂,其特征是还可以采用以下重量份个原料药制成:马钱子03-120,苍术520-900,麻黄60-120,桂枝400-600,防风430-700,川乌400-800,羌活400-800,没药400-800,杜仲430-800,仙茅310-580,黄芪500-1000,仙灵脾500-1000,当归300-800,白术500-1000,薏苡仁500-1000,白芍400-600,知母300-400,川芎500-700,丹参700-1000,草乌400-650,龙骨300-600,牡蛎300-600,独活400-600,青风藤400-800,生地黄500-1000,白花蛇舌草500-1000,金银花400-600。
6、如权利要求5的一种蠲痺定痛的中药制剂,其特征是可以优选为以下重量份个原料药制成:炙马钱子0.3,炒苍术520,麻黄60,桂枝400,防风430,制川乌400,羌活400,没药400,炒杜仲430,仙茅310,黄芪500,仙灵脾500,当归300,白术500,生薏苡仁500,白芍400,知母300,川芎500,丹参700,制草乌400,生龙骨300,生牡蛎300,独活400,青风藤400,生地黄500,白花蛇舌草500,金银花400。
7、如权利要求5的一种蠲痺定痛的中药制剂,其特征是可以优选为以下重量份个原料药制成:炙马钱子120,炒苍术900,麻黄120,桂枝600,防风700,制川乌800,羌活800,没药800,炒杜仲800,仙茅580,黄芪1000,仙灵脾1000,当归800,白术1000,生薏苡仁1000,白芍600,知母400,川芎700,丹参1000,制草乌650,生龙骨600,生牡蛎600,独活600,青风藤800,生地黄1000,白花蛇舌草1000,金银花600。
8、如权利要求5的一种蠲痺定痛的中药制剂,其特征是可以优选为以下重量份个原料药制成:炙马钱子50,炒苍术700,麻黄90,桂枝500,防风600,制川乌600,羌活600,没药600,炒杜仲600,仙茅500,黄芪800,仙灵脾800,当归600,白术800,生薏苡仁800,白芍500,知母350,川芎600,丹参900,制草乌500,生龙骨500,生牡蛎500,独活500,青风藤600,生地黄800,白花蛇舌草800,金银花500。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510018097XA CN1317021C (zh) | 2005-10-17 | 2005-10-17 | 一种蠲痺定痛的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510018097XA CN1317021C (zh) | 2005-10-17 | 2005-10-17 | 一种蠲痺定痛的中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1768791A true CN1768791A (zh) | 2006-05-10 |
CN1317021C CN1317021C (zh) | 2007-05-23 |
Family
ID=36750496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200510018097XA Expired - Fee Related CN1317021C (zh) | 2005-10-17 | 2005-10-17 | 一种蠲痺定痛的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1317021C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101939018B (zh) * | 2008-02-19 | 2013-02-20 | 庆熙大学产学协力团 | 预防和治疗关节炎疾病的包含混合草药金银花和知母提取物的组合物 |
CN103948872A (zh) * | 2014-05-12 | 2014-07-30 | 胡梁谱 | 一种治疗银屑病关节炎的中药配方 |
CN105288232A (zh) * | 2015-10-30 | 2016-02-03 | 吴小斌 | 一种治疗风湿骨病的中药胶囊及其制备方法 |
US9295705B2 (en) * | 2010-11-08 | 2016-03-29 | Development Center For Biotechnology | Treatment for nephritis |
CN110201074A (zh) * | 2019-06-27 | 2019-09-06 | 叶常青 | 一种通痹中药胶丸及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1270811A (zh) * | 2000-06-08 | 2000-10-25 | 烟台康平药业有限公司 | 一种用于治疗痹证的中成药及其制法 |
-
2005
- 2005-10-17 CN CNB200510018097XA patent/CN1317021C/zh not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101939018B (zh) * | 2008-02-19 | 2013-02-20 | 庆熙大学产学协力团 | 预防和治疗关节炎疾病的包含混合草药金银花和知母提取物的组合物 |
US9295705B2 (en) * | 2010-11-08 | 2016-03-29 | Development Center For Biotechnology | Treatment for nephritis |
CN103948872A (zh) * | 2014-05-12 | 2014-07-30 | 胡梁谱 | 一种治疗银屑病关节炎的中药配方 |
CN103948872B (zh) * | 2014-05-12 | 2017-02-15 | 胡梁谱 | 一种治疗银屑病关节炎的中药 |
CN105288232A (zh) * | 2015-10-30 | 2016-02-03 | 吴小斌 | 一种治疗风湿骨病的中药胶囊及其制备方法 |
CN110201074A (zh) * | 2019-06-27 | 2019-09-06 | 叶常青 | 一种通痹中药胶丸及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1317021C (zh) | 2007-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101874867B (zh) | 治疗银屑病中药剂 | |
CN104383363A (zh) | 治疗痛风的中药组合物 | |
CN1315526C (zh) | 一种治疗腰间盘突出、骨质增生的中草药 | |
CN101181568B (zh) | 一种治骨质增生及关节疼痛的中药制剂 | |
CN103463586A (zh) | 一种治疗不安腿综合征的中药组合物 | |
CN102247497A (zh) | 一种治疗类风湿性关节炎的中成药 | |
CN101690768B (zh) | 筋痹活络丸 | |
CN101966298B (zh) | 一种治疗风寒麻木的中药 | |
CN104000890B (zh) | 调和肝脾、祛风除湿、养血止痹痛的中药 | |
CN102475868A (zh) | 一种风湿药酒 | |
CN1317021C (zh) | 一种蠲痺定痛的中药制剂 | |
CN103330863A (zh) | 治疗腰腿疼痛的中药制剂 | |
CN103316296B (zh) | 一种治疗骨质增生的中药组合物 | |
CN105832947A (zh) | 一种养生保健的泡脚中草药粉 | |
CN105012833A (zh) | 一种多发性神经病的中药 | |
CN102512560B (zh) | 一种治疗痹症的中药组合物 | |
CN103721082A (zh) | 一种治疗肩周炎的中药组合物 | |
CN102512543B (zh) | 一种治疗类风湿的中药组合物 | |
CN106139015A (zh) | 一种治疗颈肩腰腿痛的中药组合物 | |
CN101204494A (zh) | 一种治疗慢性肠炎的药物 | |
CN105288481A (zh) | 一种治痹止痛的中药组合物及其膏剂的制备方法 | |
CN105233001A (zh) | 一种治疗男性性功能障碍不育的中药及其制备方法 | |
CN1286500C (zh) | 治疗关节疼痛的药物 | |
CN106344793A (zh) | 一种治疗关节炎的中药足浴粉及其制备方法 | |
CN1113667C (zh) | 一种治疗风湿、类风湿病的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |